Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing …
!["ANAVEX®3-71 Phase 2 Clinical Study"](https://i0.wp.com/globalpharmalive.com/wp-content/uploads/2024/03/pexels-photo-3735718-1.webp?resize=600%2C400&ssl=1)
!["ANAVEX®3-71 Phase 2 Clinical Study"](https://i0.wp.com/globalpharmalive.com/wp-content/uploads/2024/03/pexels-photo-3735718-1.webp?resize=600%2C400&ssl=1)
Pharma News From Around The World
Pharma News From Around The World
Pharma News From Around The World
Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing …
Beckman Coulter Diagnostics, a clinical diagnostics leader, and Fujirebio, a leader in neurological markers and …
ProLynx Inc. announced today that the first patient was treated with PLX038 (PEGylated SN-38) in …
Genetic information collected from seemingly healthy tissue near lung tumors may be a better predictor …